Digital Therapeutics & Medical Devices for Migraine Market Size is predicted to witness a 8.6% CAGR during the forecast period for 2024-2031.
Digital therapeutics and medical devices for migraines describe interventions that use technology to alleviate and control migraine symptoms. Mindfulness exercises and cognitive behavioral therapy for migraine symptom management are common in digital treatments. Several factors contribute to the market growth in the coming years, such as developments in digital health technology, heightened migraine awareness and prevalence, and a rising desire for alternatives to pharmaceutical treatments. Further factors fueling market growth include the increasing availability of telemedicine services and the development of AI and ML-powered tailored healthcare solutions. In addition, digital therapeutics and medical devices for migraines are seeing increased use as digital health solutions become more acceptable and are used by patients and healthcare providers worldwide, driving market expansion.
However, digital therapeutics & medical devices for migraine market slow down the market growth due to various factors such as their high cost, challenges with regulations, expensive development and implementation, and worries over data safety and confidentiality. Moreover, the market is expected to experience growth throughout the forecast time period due to technological advancements, strong alliances with government agencies, a younger population, and an increase in healthcare expenditure.
The digital therapeutics & medical devices for migraine market is segmented based on type, age group, and mode of action. Based on type, the market is segmented into arm devices, neck devices, head/forehead devices, and others. By age group, the market is segmented into those above 18 years and those above 12 years. By mode of action, the market is segmented into electrical pulse, mild electrical stimulation, and deep muscle treatment.
The head/forehead device category will hold a major share of the global digital therapeutics & medical devices for migraine market in 2023. This is because of the straightforward way they relieve migraine symptoms. These gadgets offer a non-invasive and drug-free solution by utilizing monitoring techniques. They are becoming popular as an alternative to standard pharmaceutical therapies due to their efficacy and user-friendliness, driving market expansion.
The above 18 years segment is projected to grow rapidly in the global digital therapeutics & medical devices for migraine market because migraines frequently strike adults. Due to the desire to avoid drug usage and keep productivity high, more and more adults are looking for effective non-pharmacological ways to control migraines. This is especially true among working-age adults. The increasing knowledge and willingness of this demographic to embrace digital health solutions also contribute to the segment’s growth in the future.
The North American digital therapeutics & medical devices for migraine market is expected to record the maximum market share in revenue in the near future. The region is propelled because of the substantial investment in healthcare technology, the widespread use of digital health solutions, and the well-developed healthcare infrastructure. In addition, the Asia Pacific region’s market is anticipated to experience expansion in the global market for digital therapeutics & medical devices for migraine due to the region’s rising healthcare spending and emphasis on research and innovation on non-pharmacological therapies for migraines. In addition, the Asia Pacific region is likely to experience industrial expansion because of the rising cost of healthcare, the incidence of migraine problems, and the growing interest in digital health solutions. This trend is further accelerated by the development of new technologies and the growth of healthcare infrastructure, which drives the market growth in this area.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 8.6% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, Age Group, And Mode Of Action |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Relivion MG, gammaCore, WeatherX, Aculief, Theragun, Allay Lamp, Allodynic Therapeutics, LLC, Amgen Inc., Bayer AG, Cefaly Technology, Cirrus Healthcare Products, electroCore, Inc, Eli Lilly and Company, eNeura Inc., GlaxoSmithKline plc., Neurolief Ltd., Neuros Medical, Inc., Novartis AG, Pfizer Inc., Salvia BioElectronics B.V., and Theranica Bio-Electronics Ltd., and other market players. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Digital Therapeutics & Medical Devices for Migraine Market Snapshot
Chapter 4. Global Digital Therapeutics & Medical Devices for Migraine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. By Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type:
5.2.1. Arm Device
5.2.2. Neck Device
5.2.3. Head/Forehead Device
5.2.4. Others
Chapter 6. Market Segmentation 2: By Age Group Estimates & Trend Analysis
6.1. By Age Group & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Age Group:
6.2.1. Above 18 Years
6.2.2. Above 12 Years
Chapter 7. Market Segmentation 3: By Mode Of Action Estimates & Trend Analysis
7.1. By Mode Of Action & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Mode Of Action:
7.2.1. Electrical Pulse
7.2.2. Mild Electrical Stimulation
7.2.3. Deep Muscle Treatment
Chapter 8. Digital Therapeutics & Medical Devices for Migraine Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts By Type, 2019-2031
8.1.2. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts By Age Group, 2019-2031
8.1.3. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts By Mode Of Action, 2019-2031
8.1.4. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, 2019-2031
8.2.2. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, 2019-2031
8.2.3. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, 2019-2031
8.2.4. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, 2019-2031
8.3.2. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, 2019-2031
8.3.3. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, 2019-2031
8.3.4. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
8.4.2. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031
8.4.3. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, (US$ Million) 2019-2031
8.4.4. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Relivion MG
9.2.2. gammaCore
9.2.3. WeatherX
9.2.4. Aculief
9.2.5. Theragun
9.2.6. Allay Lamp
9.2.7. Shakti Mat
9.2.8. Allodynic Therapeutics, LLC
9.2.9. Amgen Inc.
9.2.10. Bayer AG
9.2.11. Cefaly Technology
9.2.12. Cirrus Healthcare Products
9.2.13. electroCore, Inc
9.2.14. Eli Lilly and Company
9.2.15. eNeura Inc.
9.2.16. GlaxoSmithKline plc.
9.2.17. Neurolief Ltd.
9.2.18. Neuros Medical, Inc.
9.2.19. Novartis AG
9.2.20. Pfizer Inc.
9.2.21. Salvia BioElectronics B.V.
9.2.22. Theranica Bio-Electronics Ltd.
9.2.23. Other Prominent Players
Digital Therapeutics & Medical Devices for Migraine Market By Type-
Digital Therapeutics & Medical Devices for Migraine Market By Age-Group-
Digital Therapeutics & Medical Devices for Migraine Market By Mode of Action-
Digital Therapeutics & Medical Devices for Migraine Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
